These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 12241875)

  • 21. Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis.
    Stoecklein NH; Klein CA
    Int J Cancer; 2010 Feb; 126(3):589-98. PubMed ID: 19795462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular phenotyping of circulating tumour cells in patients with prostate cancer: prediction of distant metastases.
    Giesing M; Driesel G; Molitor D; Suchy B
    BJU Int; 2012 Dec; 110(11 Pt C):E1202-11. PubMed ID: 23046102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating tumour cells in breast cancer--review.
    Vertakova KB; Sanislo L; Spanik S; Svec J; Ondrus D
    Klin Onkol; 2010; 23(2):86-91. PubMed ID: 20465086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating tumour cells: insights into tumour heterogeneity.
    Hayes DF; Paoletti C
    J Intern Med; 2013 Aug; 274(2):137-43. PubMed ID: 23844916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disseminated tumor cells versus micrometastasis: definitions and problems.
    Hermanek P
    Anticancer Res; 1999; 19(4A):2771-4. PubMed ID: 10470239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymerase chain reaction in the detection of micrometastases and circulating tumor cells.
    Ghossein RA; Rosai J
    Cancer; 1996 Jul; 78(1):10-6. PubMed ID: 8646704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and characterisation of minimal residual disease in solid tumors.
    Pantel K; Otte M
    Acta Med Austriaca Suppl; 2000; 52():8-12. PubMed ID: 11261279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast-cancer stromal cells with TP53 mutations and nodal metastases.
    Patocs A; Zhang L; Xu Y; Weber F; Caldes T; Mutter GL; Platzer P; Eng C
    N Engl J Med; 2007 Dec; 357(25):2543-51. PubMed ID: 18094375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular detection of micrometastases and circulating tumor cells in melanoma prostatic and breast carcinomas.
    Ghossein RA; Carusone L; Bhattacharya S
    In Vivo; 2000; 14(1):237-50. PubMed ID: 10757082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
    Riethdorf S; Pantel K
    Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the way to specifically targeting minimal residual disease?
    Gebauer G
    Breast Cancer Res; 2008; 10(5):112. PubMed ID: 18947365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases.
    Torres L; Ribeiro FR; Pandis N; Andersen JA; Heim S; Teixeira MR
    Breast Cancer Res Treat; 2007 Apr; 102(2):143-55. PubMed ID: 16906480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Micrometastatic disease in breast cancer: clinical implications.
    Ignatiadis M; Georgoulias V; Mavroudis D
    Eur J Cancer; 2008 Dec; 44(18):2726-36. PubMed ID: 19056036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases.
    Stapleton AM; Timme TL; Gousse AE; Li QF; Tobon AA; Kattan MW; Slawin KM; Wheeler TM; Scardino PT; Thompson TC
    Clin Cancer Res; 1997 Aug; 3(8):1389-97. PubMed ID: 9815823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Minimal residual disease in breast cancer: detection and clinical relevance].
    Pantel K; Wölfle U
    Verh Dtsch Ges Pathol; 2005; 89():68-75. PubMed ID: 18035675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of disseminated tumor cells in gastrointestinal cancer.
    Thorban S; Rosenberg R; Maak M; Friederichs J; Gertler R; Siewert JR
    Expert Rev Mol Diagn; 2006 May; 6(3):333-43. PubMed ID: 16706737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of disseminated tumor cells: strategies and diagnostic implications.
    Zehentner BK
    Expert Rev Mol Diagn; 2002 Jan; 2(1):41-8. PubMed ID: 11963801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in allelic imbalances in locally advanced breast cancers after chemotherapy.
    Varna M; Soliman H; Feugeas JP; Turpin E; Chapelin D; Legrès L; Plassa LF; de Roquancourt A; Espié M; Misset JL; Janin A; de Thé H; Bertheau P
    Br J Cancer; 2007 Oct; 97(8):1157-64. PubMed ID: 17876337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection and management of bone marrow micrometastases in breast cancer.
    Osborne MP; Rosen PP
    Oncology (Williston Park); 1994 Aug; 8(8):25-31; discussion 35-6, 39-42. PubMed ID: 7947000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of disseminated tumour cells in blood and bone marrow samples of patients undergoing hepatic resection for metastasis of colorectal cancer.
    Vlems FA; Diepstra JH; Punt CJ; Ligtenberg MJ; Cornelissen IM; van Krieken JH; Wobbes T; van Muijen GN; Ruers TJ
    Br J Surg; 2003 Aug; 90(8):989-95. PubMed ID: 12905553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.